InChI=1S/C22H37NO3/c24-20-17-15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-18-22(26)23-19-21-25/h1,3-4,6-7,9-10,12,24-25H,2,5,8,11,13-21H2,(H,23,26)/b3-1-,6-4-,9-7-,12-10- |
QRMZDMUHHZLRMH-DTLRTWKJSA-N |
C(CCCO)C/C=C\C/C=C\C/C=C\C/C=C\CCCC(NCCO)=O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via endocannabinoid )
cannabinoid receptor agonist
An agonist that binds to and activates cannabinoid receptors.
(via cannabinoid )
|
|
(5Z,8Z,11Z,14Z)-20-hydroxy-N-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide
|
20-HETE-EA
|
LIPID MAPS
|
20-HETE-ethanolamine
|
HMDB
|
20-hydroxy-5,8,11,14-eicosatetraenoic acid ethanolamide
|
ChEBI
|
20-hydroxy-5,8,11,14-icosatetraenoic acid ethanolamide
|
ChEBI
|
20-hydroxyanandamide
|
ChEBI
|
20-hydroxyarachidonic acid ethanolamide
|
ChEBI
|
N-(20-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine
|
UniProt
|
N-(20-hydroxy-5Z,8Z,11Z,14Z-icosatetraenoyl)ethanolamine
|
ChEBI
|
N-[5Z,8Z,11Z,14Z-20-hydroxyicosatetraenoyl]ethanolamine
|
ChEBI
|